What's Happening?
The U.S. Court of Appeals for the Eleventh Circuit has ruled that False Claims Act (FCA) whistleblower suits do not violate Article II of the U.S. Constitution. This decision allows a Medicare fraud lawsuit brought by whistleblower Clarissa Zafirov against
Florida Medical Associates to proceed. The appeals panel reversed a 2024 federal district court opinion by Judge Kathryn Kimball Mizelle, which had argued that FCA whistleblower suits violate the appointments clause of Article II by allowing 'unaccountable' private actors to sue on the government's behalf. The Eleventh Circuit concluded that whistleblowers do not hold continuous positions and therefore are not officers requiring presidential appointment. This ruling aligns with other circuits, preventing a split in appellate court decisions on this issue. The Justice Department, which recovered $6.8 billion from FCA suits in fiscal year 2025, with $5.3 billion from whistleblower suits, is expected to welcome this decision.
Why It's Important?
This ruling is a significant victory for the False Claims Act and its role in combating fraud against the federal government. By affirming the constitutionality of whistleblower provisions, the Eleventh Circuit has reduced the immediate likelihood of the U.S. Supreme Court taking up and potentially undermining the law. The FCA is a critical tool for recovering taxpayer money lost to fraud in federal programs, and its continued strength ensures that private citizens can assist in holding entities accountable. The decision also provides clarity and stability for whistleblowers and their legal representatives, who can now proceed with cases without the immediate threat of constitutional challenges based on the appointments clause. The Justice Department heavily relies on these suits, especially in cases where it cannot intervene directly, making the preservation of this mechanism vital for federal anti-fraud efforts.
What's Next?
While the Eleventh Circuit's decision is a significant step, the legal battle may not be entirely over. The defendant in the case, Florida Medical Associates, could still file a petition to the Supreme Court. However, legal experts suggest that the absence of a circuit split makes it less likely for the Supreme Court to grant certiorari. Similar constitutional disputes are also pending in the Third and Fifth circuits, meaning the issue could still be litigated in other courts. The district court, on remand, will evaluate whether FCA whistleblowers violate the take care and vesting clauses in Article II, arguments that were not addressed by Judge Mizelle in her initial ruling. Should the Supreme Court eventually reverse the Eleventh Circuit, the Justice Department could potentially establish its own whistleblower program to replace the current provisions.
Beyond the Headlines
The ongoing debate surrounding the constitutionality of the False Claims Act's whistleblower provisions touches upon fundamental questions of executive power and the role of private citizens in enforcing federal law. Justice Clarence Thomas and Justice Brett Kavanaugh have previously expressed concerns that these provisions might be inconsistent with Article II, suggesting a potential long-term vulnerability for the FCA. This case highlights the tension between ensuring government accountability through citizen action and maintaining the executive branch's authority over law enforcement. The outcome of such challenges could redefine the balance of power and influence the future of anti-fraud efforts, potentially leading to new legislative or administrative approaches to combating fraud if the current system is deemed unconstitutional. The broader implication is how the judiciary interprets the separation of powers in the context of modern regulatory and enforcement mechanisms.
